Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical gentamicin-collagen sponge plus systemic antibiotics for infected diabetic foot ulcers
NL-OMON43839Phase 3Active, not recruiting
- Sponsor
- Innocoll
- Start
- Mar 2016
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of gentamicin in diabetic foot infection (DFI) and diabetic foot ulcer (DFU) (3 arms), sponsored by Innocoll. Primary endpoint: Clinical cure at follow-up visit 1. Started Mar 2016; status: active, not recruiting.
02
Drugs
gentamicin
03
Conditions
diabetic foot infection (DFI)diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NL-OMON43839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43839.